- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 54-68 of
232 results
1033 Exhibit: EP 0214779
Document
IPR2020-00295, No. 1033-34 Exhibit - EP 0214779 (P.T.A.B. Dec. 24, 2019)
|
|
Cite Document
1041 Exhibit: LOFTSSON et al, Cyclodextrins in eye drop formulations enhanced to...
Document
IPR2020-00295, No. 1041-42 Exhibit - LOFTSSON et al, Cyclodextrins in eye drop formulations enhanced topical delivery of corticosteroids to the eye, Acta Ophthamologica Scandinavica, 2002...
|
|
Cite Document
1016 Exhibit: Apotex, Inc v Alcon Research Ltd, IPR2016 01640, Paper 2 PTAB Au...
Document
IPR2020-00295, No. 1016-17 Exhibit - Apotex, Inc v Alcon Research Ltd, IPR2016 01640, Paper 2 PTAB Aug 18, 2016 (P.T.A.B. Dec. 24, 2019)
|
|
Cite Document
1004 Exhibit: YANNI et al, The In Vitro and In Vivo Ocular Pharmacology of Olopata...
Document
IPR2020-00295, No. 1004-4 Exhibit - YANNI et al, The In Vitro and In Vivo Ocular Pharmacology of Olopatadine AL 4943A, an Effective Anti AllergicAntihistaminic Agent, Journal of Ocular Pharm...
|
|
Cite Document
1021 Exhibit: Argentum Pharm LLC v Alcon Research, Ltd, IPR2016 00544, Paper ...
Document
IPR2020-00295, No. 1021-22 Exhibit - Argentum Pharm LLC v Alcon Research, Ltd, IPR2016 00544, Paper 1 PTAB Feb 2, 2016 (P.T.A.B. Dec. 24, 2019)
|
|
Cite Document
1040 Exhibit: Nandi et al, NANDI et al, Synergistic Effect of PEG 400 and Cyclodext...
Document
IPR2020-00295, No. 1040-41 Exhibit - Nandi et al, NANDI et al, Synergistic Effect of PEG 400 and Cyclodextrin to Enhance Solubility of Progesterone, AAPS PharmSciTech 2003 4 1, pp 1 5 (P.T...
|
|
Cite Document
1003 Exhibit: WO 2008015695 A2 Bhowmick
Document
IPR2020-00295, No. 1003-3 Exhibit - WO 2008015695 A2 Bhowmick (P.T.A.B. Dec. 24, 2019)
|
|
Cite Document
1014 Exhibit: Declaration of Dr Laskar
Document
IPR2020-00295, No. 1014-15 Exhibit - Declaration of Dr Laskar (P.T.A.B. Dec. 24, 2019)
|
|
Cite Document
1033 Exhibit: EP 0214779
Document
IPR2020-00295, No. 1033-34 Exhibit - EP 0214779 (P.T.A.B. Dec. 24, 2019)
|
|
Cite Document
1036 Exhibit: US Pat No 5,116,863
Document
IPR2020-00295, No. 1036-37 Exhibit - US Pat No 5,116,863 (P.T.A.B. Dec. 24, 2019)
|
|
Cite Document
1028 Exhibit: Leonardi, et al, The anti allergic effects of a cromolyn sodium chlorph...
Document
IPR2020-00295, No. 1028-29 Exhibit - Leonardi, et al, The anti allergic effects of a cromolyn sodium chlorpheniramine combination compared to ketotifen in the conjunctival allergen challenge m...
|
|
Cite Document
1017 Exhibit: Alcon Research, Ltd v Watson Labs, 1 15 cv 01159 D Del Paper 69 No...
Document
IPR2020-00295, No. 1017-18 Exhibit - Alcon Research, Ltd v Watson Labs, 1 15 cv 01159 D Del Paper 69 November 18, 2016 (P.T.A.B. Dec. 24, 2019)
|
|
Cite Document
1032 Exhibit: Orange Book entry for PAZEO
Document
IPR2020-00295, No. 1032-33 Exhibit - Orange Book entry for PAZEO (P.T.A.B. Dec. 24, 2019)
|
|
Cite Document
1010 Exhibit: File Wrapper for US Provisional Appl No 61548,957
Document
IPR2020-00295, No. 1010-11 Exhibit - File Wrapper for US Provisional Appl No 61548,957 (P.T.A.B. Dec. 24, 2019)
|
|
Cite Document
1030 Exhibit: Alcon Research, Ltd v Watson Labs, 1 15 cv 01159 D Del Paper 155 M...
Document
IPR2020-00295, No. 1030-31 Exhibit - Alcon Research, Ltd v Watson Labs, 1 15 cv 01159 D Del Paper 155 March 1, 2018 (P.T.A.B. Dec. 24, 2019)
|
|
Cite Document
